Sidley has advised the Special Restructuring Committee of Genesis Healthcare, Inc. The Special Restructuring Committee of Genesis Healthcare, Inc. (NYSE: GEN) has secured a settlement valued...
Genesis Healthcare Reaches US$640 Million Settlement in Bankruptcy Litigation
Vi-Jon Initiates Pre-Arranged Chapter 11 Filing to Address Talc-Related Claims
Sidley has represented Vi-Jon, LLC. Vi-Jon, LLC (Vi-Jon), a leading American provider of personal-care products and the oldest private label manufacturer in the United States, filed...
Ingredion’s £2.7 Billion Cash Acquisition of Tate & Lyle
Linklaters has advised Tate & Lyle. Hogan Lovells has represented Ingredion. Ingredion Incorporated has announced a recommended all-cash offer for the acquisition of Tate & Lyle...
Prospect Medical Holdings Secures Plan Confirmation in US$2.3 Billion Chapter 11 Restructuring
Sidley Austin has advised Prospect Medical Holdings, Inc. Prospect Medical Holdings, Inc. has secured confirmation of its Chapter 11 plan by the U.S. Bankruptcy Court for...
IonQ Acquires Oxford Ionics in $1.075 Billion Deal
Hogan Lovells has advised Oxford Ionics; Paul, Weiss has advised IonQ. Oxford Ionics has entered into a definitive agreement for its proposed sale to IonQ in...
Prospect Medical Holdings’ Chapter 11 Proceedings
Sidley Austin represented Prospect Medical Holdings Inc. in the transaction, and Paul Hastings advised the Official Committee of Unsecured Creditors. Prospect Medical Holdings Inc. (Prospect) initiated...
Verona Pharma’s $650 Million Financing Round
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Conn’s Chapter 11 Bankruptcy Proceedings
Sidley Austin is representing Conn’s Inc. in the deal, and Simpson Thacher & Bartlett is representing JPMorgan Chase Bank, N.A. as Prepetition ABL Agent and DIP...
Amylyx Pharmaceuticals’ Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals
Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...
Kaltroco’s Minority Investment in Dave Cantin Group
Hogan Lovells acted for Dave Cantin Group on the deal. The Dave Cantin Group (DCG), a leading advisor to retail automotive groups and their owners, received...
Acerus Pharmaceuticals’ Reverse Vesting Transaction
Sidley advised Acerus Pharmaceuticals on the restructuring. Acerus Pharmaceuticals recently obtained a novel order from the United States Bankruptcy Court for the District of Delaware recognizing...
Accelerate Diagnostics’ Successful Restructuring
Sidley advised Accelerate Diagnostics on the operation. Accelerate Diagnostics, Inc. completed the out of court restructuring of its $92 million in funded debt. The company closed...